Related Experiment Videos
Bringing Biosimilars to the Clinic: What's the Fuss?
Journal of the National Comprehensive Cancer Network : JNCCN
|January 7, 2016
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Modulation of myeloid and T cells in vivo by Bruton's tyrosine kinase inhibitor ibrutinib in patients with metastatic pancreatic ductal adenocarcinoma.
Journal for immunotherapy of cancer·2023
Comparative Cost-Effectiveness Analysis of First-Line Immunotherapy for Advanced Melanoma Based on 10-Year Clinical Outcomes.
Journal of the National Comprehensive Cancer Network : JNCCN·2026
New Paradigms in the Management of Castleman Disease.
Journal of the National Comprehensive Cancer Network : JNCCN·2026
Fostering Improvements in Equitable Care Delivery: Insights From the Health Equity Report Card (HERC) Pilot in Academic Cancer Centers.
Journal of the National Comprehensive Cancer Network : JNCCN·2026
County-Level Medical Debt and Its Associations With Cancer Stage and Survival in the United States.
Journal of the National Comprehensive Cancer Network : JNCCN·2026
Mesothelioma: Pleural, Version 3.2026, NCCN Clinical Practice Guidelines In Oncology.
Journal of the National Comprehensive Cancer Network : JNCCN·2026
Current Surgical Perspectives for Pleural Mesothelioma.
Journal of the National Comprehensive Cancer Network : JNCCN·2026
Deficiency of GLUT1 in macrophages reprograms tumor-associated macrophages to normalize tumor vasculature and retards the progression of tumors.
International journal of biological sciences·2026
From static risk to dynamic disease monitoring: the role of MRD and immune profiling in multiple myeloma.
Frontiers in immunology·2026
Doravirine and islatravir for HIV-1 treatment: A systematic review and meta-analysis with GRADE assessment.
Therapeutic advances in infectious disease·2026
Advancement in Inflammation-responsive Drug Delivery System for Chronic Inflammation.
Anti-inflammatory & anti-allergy agents in medicinal chemistry·2026